Medically reviewed by Dr Sin Yong · Last reviewed
Published 9 October 2026 · Reviewed by Dr Sin Yong

A lump, ridge, bluish tint or puffiness under the eye after tear trough filler is a frequent reason people seek a second opinion. Most have an identifiable cause, and many can be corrected. The first step is working out what the lump actually is: product placed too superficially, fluid, filler that has stayed far longer than expected, an inflammatory nodule, or a collagen-stimulating filler that hyaluronidase cannot dissolve.
Under-eye filler lumps & nodules: the full guide → · Filler correction →
LookalikesOften confused with eye bags that predate filler: a lump or ridge that appeared after treatment, has an edge on gentle palpation or carries a bluish tint points to filler; a bulge that enlarges on looking up is orbital fat. eye bags and fat prolapse.
Because the lower eyelid is the least forgiving place in the face to put filler. The skin is among the thinnest on the body, there is very little fat between it and the muscle, and the area drains fluid poorly. A volume of filler that would be invisible in the cheek can show as a ridge or bead under the eye, and a gel that draws in water can turn a hollow into a bag. The infraorbital hollow has been described as the area of the face most prone to filler adverse events (Funt, J Clin Aesthet Dermatol 2011).
Anatomy explains much of it. A true ligament, the tear trough ligament, tethers the skin to bone along the inner lower eyelid and continues outward as the orbicularis retaining ligament (Wong, Plast Reconstr Surg 2012). Along the tear trough the muscle attaches directly to bone; along the lid–cheek junction it attaches through that ligament, which is why cadaver work suggests different depths for the two areas (Haddock, Plast Reconstr Surg 2009). Filler placed above those planes, or too much of it, is what tends to show.
Timing, feel and colour narrow it down before any treatment is discussed. The table below is a starting point for a conversation with a doctor, not a diagnosis.
| What you notice | Usually appears | What it often is | First step |
|---|---|---|---|
| Firm or lumpy area, bruising, swelling | Soon after the injection, easing as it settles | Normal swelling, bruising or product not yet settled | Gentle care and review; avoid pressing or massaging unless advised |
| A visible or palpable bead or ridge | Days to weeks, persisting | Filler placed too superficially or in too large a bolus | Examination and ultrasound; targeted hyaluronidase if it is HA |
| Bluish or grey tint under the eye | Weeks, persisting | Tyndall effect: superficial HA scattering light | Targeted hyaluronidase to the superficial deposit |
| Puffy bags that worsen in the morning or after salt | Weeks to years | Malar oedema, or retained filler drawing in water | Distinguish fluid from filler; dissolve filler if present |
| New tender or firm nodule | Months or years later | Delayed-onset nodule: inflammatory reaction, biofilm or granuloma | Tender: a doctor the same day, or A&E if no doctor can see you today. Otherwise assessment first; not more filler and not guesswork |
| Hard lump after Sculptra, Radiesse, Ellansé or Juvelook | Weeks to months | Collagen-stimulator material clustering | Ultrasound; the Sculpting mode of Time Freeze Laser LCLR®, without an incision (hyaluronidase cannot dissolve these) |
| Pale, dusky or mottled skin; vision change | Usually during or soon after the injection, sometimes later | Possible vascular compromise | Skin or pain: urgent assessment by the doctor who injected you, or at A&E, now; vision change: call 995 now |
How common are these? In a series of 583 patients who had 1,452 tear trough treatments with a mean of 0.34 mL per side, swelling occurred in 10%, contour irregularity in 4.6% and a bluish tint in 3.3%, and filler was dissolved in 1.9% of eyes; larger volumes significantly increased the risk of swelling (Wilde, PRS Global Open 2023). Most adverse events after hyaluronic acid filler are mild, transient and related to volume and technique (Signorini, Plast Reconstr Surg 2016; Funt and Pavicic, Clin Cosmet Investig Dermatol 2013).

He starts with the history: which product, how much, when, by whom, and whether there have been top-ups. Records from the previous clinic help, but many patients do not know what was injected, and that is common. He then palpates the area, looks at the eyes at rest and in expression, including a full smile, and marks where the concern is. Only then is ultrasound used to show what is there: whether the material looks like hyaluronic acid or something else, how deep it sits, whether it is one deposit or several small pockets, and where the nearby vessels run.
That order matters. A lump and the swelling around it are often in different places, and the material that is causing a problem may not be where the patient points. Ultrasound-guided hyaluronidase, described in the dermatology literature since at least 2016 (Quezada-Gaón and Wortsman, JEADV 2016), lets the enzyme be placed into the deposit rather than around it.
“More filler cannot fix a face that already has too much filler.”
Dr Sin YongOn correcting overfilled and lumpy areas

Hyaluronic acid filler can be broken down by hyaluronidase, an enzyme injected into the filler. For non-urgent correction, published guidance recommends a small skin test dose first and treating to effect rather than to a fixed dose (King, J Clin Aesthet Dermatol 2018). Dr Sin Yong reassesses after about 48 hours and waits at least two weeks before any further filler is considered. Suspected filler in a blood vessel is different: it is treated immediately with high doses, without waiting for a test. Under the eye, the aim is selective: dissolve the deposit that is causing the lump or tint, not every trace of filler in the face.
Complete removal is not always possible in one round, particularly when filler has broken into many small pockets or has been layered over several years by different injectors. MRI studies have found hyaluronic acid filler still present in the mid-face years after injection, including in patients who had not been treated for more than five years (Master, PRS Global Open 2024), and periocular filler has been documented causing swelling up to nine years later (Chang, Ophthalmic Plast Reconstr Surg 2017). That is why old filler can be the explanation for new puffiness.
Sculptra (poly-L-lactic acid), Radiesse (calcium hydroxylapatite), Ellansé (polycaprolactone) and Juvelook are not dissolved by hyaluronidase. Lumps from these need a different plan, and nobody can honestly promise to “dissolve” them. In a review of 5,081 calcium hydroxylapatite treatments, 3% had an adverse event and 96% of those were nodules, most of which resolved (Kadouch, J Cosmet Dermatol 2017). Published options for persistent non-HA nodules range from waiting to medicines injected into the nodule (Lemperle and Gauthier-Hazan 2009; Vleggaar, J Drugs Dermatol 2014).
For excess or layered collagen-stimulator material, including under the eye, Dr Sin Yong uses the Sculpting mode of Time Freeze Laser LCLR®, which is built to target the excess; he uses it for nodules large and small, including Ellansé nodules, excess Juvelook, layered hyaluronic acid and migrated Sculptra. He uses it under the eye as well as elsewhere in the face; whether it suits a particular under-eye is decided at assessment, after ultrasound. More on this: lumps after Sculptra, Radiesse, Ellansé or Juvelook under the eye.

Many patients who come to see Dr Sin Yong about under-eye filler lumps tell him they have tried almost everything else and had given up hope. Having tried other treatments does not mean nothing more can be done: what is done next depends on what the scan shows.
Under the eye, that history is useful. A lump here can be hyaluronic acid placed too close to the thin eyelid skin, fluid trapped above the malar septum, filler that has stayed for years, or a collagen stimulator such as Sculptra, Radiesse, Ellansé or Juvelook that hyaluronidase cannot dissolve. Ultrasound helps show which of these applies, and the plan starts from there. For excess or layered collagen-stimulator material, including under the eye, Dr Sin Yong uses the Sculpting mode of Time Freeze Laser LCLR®, without an incision. How each person responds varies.
If you have been told nothing more can be done, it is still worth having the area scanned: ultrasound helps show what is there, and the plan is made from that. Bring any records of past treatments, product names and dates if you have them. More on this is in when filler dissolving has not worked.
A new, firm or tender nodule appearing months or years after filler is a different problem from a lump in the first weeks. It may be an inflammatory reaction, a low-grade infection on the surface of the filler (biofilm) or a foreign-body granuloma (Signorini 2016; Urdiales-Gálvez, Aesthetic Plast Surg 2018). A 2021 review argued that “delayed-onset nodule” is a symptom rather than a diagnosis and that tests such as ultrasound, inflammatory markers and sometimes histology should guide treatment rather than a sequence of guesses (Convery, J Clin Aesthet Dermatol 2021); published algorithms take the same staged approach (Snozzi and van Loghem, PRS Global Open 2018). These are assessed before anything is injected; a nodule that is red, hot or tender needs a doctor the same day, or A&E if no doctor can see you today.

Puffiness below the eye after filler is often malar oedema: fluid collecting in a compartment between the orbicularis retaining ligament and the zygomaticocutaneous ligament, where lymphatic drainage is poor. Recent expert recommendations list high filler volume and placement above the malar septum among the risk factors (Baranska-Rybak, Dermatol Ther 2026). Retained filler can also produce a late “pale puffy lower eyelid pillow” that is easily mistaken for festoons; one report described correction with hyaluronidase followed by fractional CO₂ laser for the remaining laxity (Lederhandler, J Drugs Dermatol 2021). More on this: under-eye filler swelling and puffiness. The bluish tint is covered on the Tyndall effect after filler.
Swelling under the eye after filler that comes and goes, or is worse in the morning, is often hyaluronic acid holding water, or filler pressing on the small veins that drain the area. When ultrasound shows filler as the cause, dissolving the excess is the usual next step rather than waiting. The steps, the small first dose and what comes afterwards are set out in under-eye filler dissolving.
If something goes wrong after tear trough filler, the first step is examination by the treating doctor, because the right response depends on what the problem is. Because the product used here is hyaluronic acid, most problems can be addressed by dissolving it with hyaluronidase, which is kept on hand at every treatment.
A bluish tint from gel sitting too superficially, a lump that persists once the swelling has gone, or a puffy over-filled look are managed by dissolving the product, sometimes after an ultrasound scan to see exactly where it sits. Malar oedema, the swelling of the cheek mounds, may also need hyaluronidase and can take longer to settle.
A blocked blood vessel is the emergency. Skin that turns pale, mottled or dusky, or pain that is increasing rather than settling, needs urgent assessment by the doctor who injected you, or at A&E, now, and the product is dissolved at once. A change in vision or eye pain after filler: call 995 now.
A lump that appears weeks later is examined rather than massaged, because infection and inflammatory nodules are managed differently from simple excess product; one that is red, warm or tender needs a doctor the same day, or A&E if no doctor can see you today. Knowing who to call, and that they will answer, is part of the plan agreed before treatment.
Once a lump has been dissolved or settled, the area is reassessed after swelling has gone down. Many people decide they do not want filler under the eye again, and for some eyes that is the right answer: a true fat bag, thin crepey skin and pigment are not filler problems, as set out on when not to have tear trough filler. Where a hollow remains and refilling is appropriate, less product, placed deeper, is the usual principle. Fees follow the plan and are set out in writing; how fees are quoted explains why they are not published.
Every treatment is performed by Dr Sin Yong personally. Singapore Medical Council registered · invited to share his clinical expertise internationally as a Key Opinion Leader for CLASSYS, DEKA, HIRONIC, FOTONA, ALMA, LUTRONIC and ILOODA · HSA-registered devices · ultrasound-guided correction
Dr Sin Yong's aesthetic clinic in Singapore is on Orchard Road, a short walk from Orchard MRT. More about the aesthetic doctor in Singapore who performs every treatment.
WhatsApp Dr Sin Yong →or use the enquiry formRelated
Full guide: tear trough filler Singapore — who it suits, how it is placed on the bone by cannula, and how problems are imaged and reversed.
Related
Guide: under eye filler Singapore — who it suits, how it is placed and how problems are reversed.
Lumps soon after treatment are often swelling or product settling and may improve. A lump, ridge or bluish tint that persists once the swelling has settled usually means filler sitting too superficially and is unlikely to resolve quickly, because hyaluronic acid can persist for years. It should be examined.
If the filler is hyaluronic acid, yes: hyaluronidase breaks it down, and placing it under ultrasound guidance lets the enzyme go into the deposit itself. Sculptra, Radiesse, Ellansé and Juvelook are not dissolved by hyaluronidase.
A bluish or grey tint is usually the Tyndall effect: hyaluronic acid placed too close to the thin eyelid skin scatters light. It is treated by dissolving that superficial deposit with targeted hyaluronidase.
Hyaluronic acid filler can persist for years and draw in water, and filler above the malar septum can trap fluid. MRI studies have found HA filler in the mid-face more than five years after injection. Separating fluid from retained filler is the first step.
Hyaluronidase is widely used and guidelines recommend a test dose first. Risks include swelling, bruising and, rarely, allergic reaction. Dissolving is selective, aiming at the deposit causing the problem rather than all filler in the area.
Dr Sin Yong waits at least two weeks after hyaluronidase before any further filler, and reassesses once swelling has settled. Many people decide not to refill under the eye at all.
It helps, but many patients do not know, and that is common. Ultrasound can show whether the material looks like hyaluronic acid or a collagen stimulator, how deep it sits and whether it is one deposit or several.
Vision change or eye pain after filler: call 995 now, and contact the injecting doctor. Skin that turns pale, dusky or mottled, or worsening pain, needs urgent assessment by the doctor who injected you, or at A&E, now. A hot, red, tender lump, with or without fever, needs a doctor the same day; if no doctor can see you today, A&E.
Wilde CL, Gupta A, Lee S, Ezra DG. Tear trough filler using the three-point tangent technique: lessons from 1452 tear trough applications. Plast Reconstr Surg Glob Open. 2023;11:e5060. doi:10.1097/GOX.0000000000005060. source
Wong CH, Hsieh MKH, Mendelson B. The tear trough ligament: anatomical basis for the tear trough deformity. Plast Reconstr Surg. 2012;129(6):1392-1402. doi:10.1097/PRS.0b013e31824ecd77. source
Haddock NT, Saadeh PB, Boutros S, Thorne CH. The tear trough and lid/cheek junction: anatomy and implications for surgical correction. Plast Reconstr Surg. 2009;123(4):1332-1340. doi:10.1097/PRS.0b013e31819f2b36. source
Funt DK. Avoiding malar edema during midface/cheek augmentation with dermal fillers. J Clin Aesthet Dermatol. 2011;4(12):32-36. PMID 22191006. source
Signorini M, Liew S, Sundaram H, et al. Global Aesthetics Consensus: avoidance and management of complications from hyaluronic acid fillers. Plast Reconstr Surg. 2016;137(6):961e-971e. doi:10.1097/PRS.0000000000002184. source
Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol. 2013;6:295-316. doi:10.2147/CCID.S50546. source
Urdiales-Gálvez F, Delgado NE, Figueiredo V, et al. Treatment of soft tissue filler complications: expert consensus recommendations. Aesthetic Plast Surg. 2018;42(2):498-510. doi:10.1007/s00266-017-1063-0. source
Snozzi P, van Loghem JAJ. Complication management following rejuvenation procedures with hyaluronic acid fillers — an algorithm-based approach. Plast Reconstr Surg Glob Open. 2018;6:e2061. doi:10.1097/GOX.0000000000002061. source
King M, Convery C, Davies E. The use of hyaluronidase in aesthetic practice (v2.4). J Clin Aesthet Dermatol. 2018;11(6):E61-E68. PMID 29942426. source
Murray G, Convery C, Walker L, Davies E. Guideline for the safe use of hyaluronidase in aesthetic medicine, including modified high-dose protocol. J Clin Aesthet Dermatol. 2021;14(8):E69-E75. PMID 34840662. source
Convery C, Davies E, Murray G, Walker L. Delayed-onset nodules (DONs) and considering their treatment following use of hyaluronic acid fillers. J Clin Aesthet Dermatol. 2021;14(7):E59-E67. PMID 34840652. source
Master M, Azizeddin A, Master V. Hyaluronic acid filler longevity in the mid-face: a review of 33 magnetic resonance imaging studies. Plast Reconstr Surg Glob Open. 2024;12(7):e5934. doi:10.1097/GOX.0000000000005934. source
Chang JR, Baharestani S, Salek SS, et al. Delayed superficial migration of retained hyaluronic acid years following periocular injection. Ophthalmic Plast Reconstr Surg. 2017;33(3S):S116-S118. doi:10.1097/IOP.0000000000000434. source
Kadouch JA. Calcium hydroxylapatite: a review on safety and complications. J Cosmet Dermatol. 2017;16(2):152-161. doi:10.1111/jocd.12326. source
Vleggaar D, Fitzgerald R, Lorenc ZP. Understanding, avoiding, and treating potential adverse events following injectable poly-L-lactic acid. J Drugs Dermatol. 2014;13(4 Suppl):s35-39. PMID 24719076. source
Lemperle G, Gauthier-Hazan N. Foreign body granulomas after all injectable dermal fillers: part 2. Treatment options. Plast Reconstr Surg. 2009;123(6):1864-1873. doi:10.1097/PRS.0b013e3181858f4f. source
Baranska-Rybak W, Lajo-Plaza JV, Walker L, Alizadeh N. Malar oedema after hyaluronic acid dermal fillers: expert recommendations on aetiology, prevention and management. Dermatol Ther (Heidelb). 2026. doi:10.1007/s13555-026-01920-w. source
Lederhandler M, Belkin D, Anolik R, Geronemus RG. The rise and fall of the pale puffy lower eyelid pillow. J Drugs Dermatol. 2021;20(4):475-476. doi:10.36849/JDD.2021.5509. source
Quezada-Gaón N, Wortsman X. Ultrasound-guided hyaluronidase injection in cosmetic complications. J Eur Acad Dermatol Venereol. 2016;30(1):e39-e40. doi:10.1111/jdv.13286. source
Consultations by appointment at Orchard Road, Singapore.
Replies within clinic hours: Mon–Fri 10am–8pm, Sat 11am–3pm · How consultations work · Prefer not to use WhatsApp? · Treatment finder
WhatsApp +65 8023 7170 →